Islet Autoantibody Patterns Differ by Race, Ethnicity, and Economic Factors

Type 1 diabetes begins with autoimmunity—the body's immune system starts attacking the insulin-producing cells in the pancreas. Long before symptoms appear, researchers can detect islet autoantibodies in the blood. These antibodies are early warning signs that someone may develop Type 1 diabetes in the future.

A new study examined screening data from nearly 140,000 relatives of people with Type 1 diabetes to understand whether autoantibody patterns differ depending on a person's race, ethnicity, or economic circumstances. The research, conducted through TrialNet between 2012 and 2022, is one of the largest efforts to examine these questions.

The study found notable differences in autoantibody positivity across racial and ethnic groups. Non-Hispanic Black participants had significantly higher odds of testing positive for autoantibodies overall—both when they had a single autoantibody and when they had multiple autoantibodies.

Hispanic individuals showed a different pattern: they had higher rates of single autoantibody positivity compared to non-Hispanic White individuals, but lower rates of multiple autoantibodies. This distinction matters because multiple autoantibodies are often considered a stronger indicator of Type 1 diabetes risk.

The researchers also examined whether neighborhood economic conditions influenced autoantibody patterns. They assigned deprivation levels to participants based on their home addresses, ranging from least to most deprived.

People living in less economically deprived areas had higher odds of testing positive for multiple autoantibodies. However, this finding raises questions that require further investigation—researchers do not yet fully understand why economic factors might relate to these patterns of autoimmunity.

These findings underscore that Type 1 diabetes autoimmunity does not develop uniformly across all populations. The variations by race, ethnicity, and socioeconomic status suggest that a one-size-fits-all approach to screening and prevention may not be optimal.

The study highlights the importance of collecting and analyzing data across diverse communities to better understand who is at risk and how best to identify and support them. As researchers develop and refine prevention strategies, accounting for these demographic and economic differences could help ensure more equitable and effective approaches to Type 1 diabetes risk management.

Source: Diabetes care. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.